Winner Medical Group Inc. Non-GAAP Reconciliation | ||||||
Three Months endedMarch 31 | Six Months endedMarch 31 | |||||
2011 | 2010 | 2011 | 2010 | |||
US$ | US$ | US$ | US$ | |||
Net income attributable to Winner Medical Group Inc. (GAAP) | 2,235,937 | 2,676,538 | 5,564,181 | 6,597,249 | ||
Share-based compensation | 244,955 | 244,215 | 526,261 | 547,118 | ||
Realized Loss on Commodity Financial Instruments | 1,340,726 | - | 1,495,719 | - | ||
Adjusted net income attributable to Winner Medical Group Inc. (Non-GAAP) | 3,821,618 | 2,920,753 | 7,586,161 | 7,144,367 | ||
Earnings per share (GAAP) | ||||||
- Basic | 0.09 | 0.12 | 0.23 | 0.29 | ||
- Diluted | 0.09 | 0.12 | 0.23 | 0.29 | ||
Adjusted earnings per share (Non-GAAP) | ||||||
- Basic | 0.16 | 0.13 | 0.31 | 0.32 | ||
- Diluted | 0.16 | 0.13 | 0.31 | 0.32 | ||
Weighted average ordinary shares outstanding | ||||||
- Basic | 24,130,247 | 22,363,740 | 24,123,266 | 22,363,740 | ||
- Diluted | 24,533,132 | 22,805,030 | 24,534,405 | 22,639,131 | ||
Three Months endedMarch 31 | Six Months endedMarch 31 | |||||
2011 | 2010 | 2011 | 2010 | |||
US$ | US$ | US$ | US$ | |||
Selling, general and administrative expenses (GAAP) | 5,801,733 | 4,139,926 | 11,857,799 | 9,463,646 | ||
Share-based compensation | 244,955 | 244,215 | 526,261 | 547,118 | ||
Adjusted selling, general and administrative expenses (Non-GAAP) | 5,556,778 | 3,895,711 | 11,331,538 | 8,916,528 | ||
